phentermine/topiramate
AssetSmall moleculeAlso phentermine, Phentermine and Topiramate, Topirmate and Phentermine
Sympathomimetic amine anorectic and neurotherapeutic agent combination suppressing appetite.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Lipid and ceramide metabolism
- Indications
- 4
- Trials
- 30
- Developers
- 1
Indications
4Diabetes
Phase 2COMPLETEDNCT00600067clinicaltrials.gov7 Oct 2026
Hepatic impairment
Phase 1COMPLETEDNCT00768209clinicaltrials.gov7 Oct 2026
Obesity
Phase 1COMPLETEDNCT00518466clinicaltrials.gov7 Oct 2026
1 more
- Targets and what it contains4
- Owner and partners1
- Trials30
- Evidence for its targets3
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 5 sources